Invizyne Technologies INC S-1 registration statements

Invizyne Technologies Inc. details the terms of a placement warrant agreement in its latest S-1/A filing, outlining conditions for purchasing common stock.

Invizyne Technologies Inc. files an amendment to its Form S-1 registration statement for its initial public offering, planning to list on the Nasdaq Capital Market under the symbol IZTC.

Invizyne Technologies Inc. is proceeding with its initial public offering, registering 3.75 million shares of common stock coupled with long-term investor rights, as detailed in Amendment No. 6 to its Form S-1 registration statement.

Invizyne Technologies Inc. files an amendment to its Form S-1 registration statement for a $15 million initial public offering, including a unique investor rights offering.

Invizyne Technologies Inc. has filed Amendment No. 4 to its Form S-1 registration statement, outlining details for its initial public offering and a secondary offering by a selling security holder.

Invizyne Technologies Inc. has filed an amendment to its Form S-1 registration statement for its initial public offering of 4,300,000 shares of common stock at $4.00 per share, while also registering shares for a selling security holder.

Invizyne Technologies seeks to go public, planning to use proceeds to expand its SimplePath biomanufacturing platform for pharmaceuticals and biofuels.

Invizyne Technologies Inc. has filed an amendment to its Form S-1 registration statement for an initial public offering of 4,300,000 shares of common stock at $4.00 per share.

Invizyne Technologies, a biomanufacturing company, has filed an S-1 registration statement for an initial public offering (IPO) to advance its SimplePath platform and revolutionize the production of chemicals.